Preeclampsia Foundation meets the 20 Standards for Charity Accountability.
-
Year, State Incorporated
2000, WA
-
-
Affiliates
Preeclampsia Foundation Canada
-
Stated Purpose
"to improve the outcomes of hypertensive disorders of pregnancy by educating, supporting and engaging the community, improving healthcare practices, and finding a cure."
Preeclampsia Foundation reports that they are a patient advocacy organization that works to serve approximately 300,000 women each year in the United States who are affected by hypertensive disorders of pregnancy such as preeclampsia, eclampsia and HELLP syndrome. The organization states that its main pillars are to educate, support and empower the community of the affected, improve healthcare practices, and fund and advocate for research to find a cause and a preeclampsia cure. The organization is advised by a medical board comprising of medical and scientific experts in preeclampsia and related fields and partners with other non-profit organizations, governmental agencies, academic institutions, and corporations.
For the year ended December 31, 2019, Preeclampsia Foundation's program expenses were:
Research |
$476,415 |
Awareness |
$315,325 |
Education |
$284,199 |
Advocacy |
$40,297 |
Total Program Expenses: |
$1,116,236 |
-
Chief Executive
Eleni Tsigas, Chief Executive Officer
-
Compensation*
$61,080
-
Chair of the Board
Kimberly Smith
-
Chair's Profession / Business Affiliation
National Manager of Practice Operations Development and Transitions, Tenet Healthcare
-
Board Size
10
-
Paid Staff Size
0
*2019 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Telephone appeals
Fundraising costs were 4% of related contributions. (Related contributions, which totaled $1,264,197, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Preeclampsia Foundation's audited financial statements for the year ended December 31, 2019.
Source of Funds |
Contributions |
$543,561 |
Grants |
$403,010 |
Special events., net |
$229,611 |
Contributed goods and services |
$88,015 |
Investment income, net |
$86,702 |
Fee based services |
$29,588 |
Merchandise sales |
$26,043 |
Other income |
$5,089 |
Total Income |
$1,411,619 |
- Programs: 84%
- Administrative: 13%
- Fundraising: 3%
Total Income |
$1,411,619 |
Program expenses |
$1,116,236 |
Fundraising expenses |
$46,847 |
Administrative expenses |
$181,748 |
Other expenses |
$0 |
Total expenses: |
$1,344,831 |
Income in Excess of Expenses |
$66,788 |
Beginning Net Assets |
$778,132 |
Other Changes In Net Assets |
$0 |
Ending Net Assets |
$844,920 |
Total Liabilities |
$272,702 |
Total Assets |
$1,117,622 |
Note: As reported in the organization’s audited financial statements for the year ended December 31, 2019, Preeclampsia Foundation received in-kind donations totaling $88,015 in the form of supplies and research services ($87,115) and admin equipment and signage ($900).